#AdvEnzymes 🚀 Advanced Enzyme Technologies Ltd – Q4 FY26 Results Breakdown 📊🔥 🗓 Quarter Ended: March 2026 ━━━━━━━━━━━━━━━ 📌 Quarterly Performance (YoY) ━━━━━━━━━━━━━━━ 💰 Revenue from Operations ➡️ ₹2,033.67 Mn ⬆️ vs ₹1,671.79 Mn 📈 Growth: 21.6% 💰 Total Income ➡️ ₹2,105.95 Mn ⬆️ vs ₹1,759.24 Mn 📈 Growth: 19.7% 💸 Total Expenses ➡️ ₹1,509.04 Mn ⬆️ vs ₹1,324.64 Mn 🔥 Profit Before Tax (PBT) ➡️ ₹598.04 Mn ⬆️ vs ₹434.60 Mn 📈 Growth: 37.6% ✅ Net Profit (PAT) ➡️ ₹452.52 Mn ⬆️ vs ₹267.28 Mn 📈 Growth: 69.3% 🚀 📊 EPS (Quarterly) ➡️ ₹3.84 ⬆️ vs ₹2.37 ━━━━━━━━━━━━━━━ 📌 FY26 Full Year Performance ━━━━━━━━━━━━━━━ 💰 Revenue from Operations ➡️ ₹7,457.57 Mn ⬆️ vs ₹6,369.10 Mn 📈 Growth: 17.1% 💰 Total Income ➡️ ₹7,805.89 Mn ⬆️ vs ₹6,699.51 Mn 💸 Total Expenses ➡️ ₹5,594.12 Mn ⬆️ vs ₹4,825.87 Mn 🔥 Profit Before Tax (PBT) ➡️ ₹2,325.36 Mn ⬆️ vs ₹1,873.64 Mn 📈 Growth: 24.1% ✅ Net Profit (PAT) ➡️ ₹1,736.08 Mn ⬆️ vs ₹1,339.74 Mn 📈 Growth: 29.6% 🚀 📊 FY26 EPS ➡️ ₹15.08 ⬆️ vs ₹11.72 ━━━━━━━━━━━━━━━ 📌 Key Business Takeaways ━━━━━━━━━━━━━━━ ⚡ Strong profit growth despite moderate expense rise ⚡ Margin expansion visible ⚡ Healthy operational efficiency ⚡ Consistent earnings momentum maintained ⚡ Export-focused specialty enzyme business performing well ━━━━━━━━━━━━━━━ 📌 Investor Watchlist 👀 ━━━━━━━━━━━━━━━ 🔹 Global demand for enzymes 🔹 Pharma & nutraceutical growth 🔹 Margin sustainability 🔹 New product pipeline 🔹 International business expansion #AdvancedEnzyme #StockMarket #IndianStocks #PharmaStocks #Earnings #Results #Investing #ShareMarket #SmallcapStocks 📈

#ADVANCEDENZYME #Q4 #RESULTS CONS. NET PROFIT UP 62.2% AT ₹42.96 CR (YOY), UP 1.1% (QOQ) REVENUE UP 21.6% AT ₹203.37 CR (YOY), UP 18.3% (QOQ) EBITDA UP 38.7% AT ₹63.23 CR (YOY), UP 28.1% (QOQ) MARGINS 31.1% V 27.3% (YOY), 28.7% (QOQ) DIVIDEND RS 1.35 BY - MARKET PULSE WHATSAPP CHANNEL

#ResultsOnZee | Advanced Enzyme कंसो मुनाफा ₹26 Cr से बढ़कर ₹43 Cr (YoY) कंसो आय ₹167 Cr से बढ़कर ₹203 Cr (YoY) #AdvancedEnzyme #StockMarket #Earnings #QuarterlyResults

Advanced Enzyme Technologies Ltd Q4FY26 Results:- #Q4Results #Q4FY26 #StockMarket #Nifty #AdvancedEnzyme 🟢 Revenue ₹204 Cr vs ₹170 Cr ( 20.00% YoY) 🟢 EBITDA ₹63.3 Cr vs ₹45.7 Cr ( 38.51% YoY) 🟢 EBITDA Margin 31.12% vs 27.33% ( 379 bps YoY) 🟢 Net Profit ₹43 Cr vs ₹26.5 Cr ( 62.26% YoY) 🟢 Margin expansion and strong earnings growth indicate improved product mix and operating leverage. 🟢 Board recommended Final Dividend of ₹1.35 per equity share. Specialty biotech and enzyme players continue to see strong demand across pharma, nutrition, and industrial segments. Sustained margin improvement will be the key trigger for re-rating. Can Advanced Enzyme maintain 30% EBITDA margins consistently going forward? 🤔 #Dividend #Biotech #Pharma #IndianStockMarket

#4QWithCNBCTV18 | #AdvancedEnzyme reports its Q4 results: 👉Net Profit Up 62.9% At ₹43 Cr Vs ₹26.4 Cr (YoY) 👉Revenue Up 8.7% At ₹203.3 Cr Vs ₹187.1 Cr (YoY) 👉EBITDA Down 3.8% At ₹63 Cr Vs ₹65.5 Cr (YoY) 👉Margin At 31% Vs 35% (YoY)

#AdvancedEnzymeTechnologies Q4 FY26 Results 🧪🔥 Quarterly Performance (Q4 FY26 vs Q4 FY25) ✅ Revenue from Operations: ₹2,033.67 Cr ⬆️ vs ₹1,671.79 Cr 📈 Growth: 21.6% YoY ✅ Other Income: ₹72.28 Cr ⬇️ vs ₹87.45 Cr ✅ Total Income: ₹2,105.95 Cr ⬆️ vs ₹1,759.24 Cr 📈 Growth: 19.7% YoY Expenses Breakdown 🔹 Cost of Materials Consumed: ₹559.61 Cr 🔹 Employee Benefit Expense: ₹419.38 Cr 🔹 Finance Cost: ₹5.73 Cr 🔹 Depreciation: ₹101.92 Cr 🔹 Other Expenses: ₹412.71 Cr ✅ Total Expenses: ₹1,509.04 Cr ⬆️ vs ₹1,324.64 Cr Profitability 🔥 ✅ Profit Before Exceptional Item & Tax: ₹596.91 Cr ⬆️ vs ₹434.60 Cr 📈 Growth: 37.3% YoY ⚠️ Exceptional Item: -₹1.31 Cr ✅ Profit Before Tax (PBT): ₹598.04 Cr ⬆️ vs ₹434.60 Cr 📈 Growth: 37.6% YoY ✅ Tax Expense: ₹145.52 Cr ✅ Net Profit (PAT): ₹452.52 Cr 🚀 vs ₹267.28 Cr 📈 Massive 69.3% YoY Growth Comprehensive Income 📊 ✅ Total Comprehensive Income: ₹931.85 Cr 🚀 vs ₹273.87 Cr ✅ Profit Attributable to Shareholders: ₹429.63 Cr ⬆️ vs ₹264.82 Cr FY26 Full Year Performance 🚀 ✅ Revenue from Operations: ₹7,457.57 Cr ⬆️ vs ₹6,369.10 Cr ✅ Total Income: ₹7,805.89 Cr ⬆️ vs ₹6,699.51 Cr ✅ Total Expenses: ₹5,594.12 Cr ⬆️ vs ₹4,825.87 Cr ✅ Profit Before Tax: ₹2,325.36 Cr ⬆️ vs ₹1,873.64 Cr ✅ Net Profit (PAT): ₹1,736.08 Cr 🚀 vs ₹1,339.74 Cr 📈 Growth: 29.6% YoY EPS Details 💰 ✅ Q4 FY26 EPS: ₹3.84 ⬆️ vs ₹2.37 YoY ✅ FY26 EPS: ₹15.08 ⬆️ vs ₹11.72 FY25 💥 Strong earnings growth 💥 Margin expansion visible 💥 Healthy operational performance 💥 Consistent yearly growth #AdvancedEnzymeTechnologies #AdvancedEnzyme #Q4Results #Earnings #StockMarket #NSE #SwingBlaster

Why is Nalanda India Equity Fund holding an 8.5% stake in Advanced Enzyme Technologies? This debt-free biotech leader dominates the enzyme and probiotic space with over 400 products and has sustained high EBITDA margins between 20-40% , reflecting strong entry barriers and significant pricing power. From B2C expansion in India via its "Wellfa" platform to pioneering the use of biocatalysts in API manufacturing, the potential growth triggers are massive. Is this a "wait and watch" or a deep value opportunity at current valuations? Watch the full fundamental analysis here: youtube.com/watch?v=e7HH-pht… #StockMarketIndia #AdvancedEnzyme #FundamentalAnalysis #Investing #Biotech

ICRA Rates Advanced Enzyme AA-; Stable, A1 Like | Share | Follow | Comment For Daily Updates. capitalmarket.com #AdvancedEnzyme #ICRA #CreditRating #AAMinus

#3QWithCNBCTV18 | #AdvancedEnzyme reports #Q3Results Net Profit up 13% at ₹42.5 cr vs ₹37.6 cr (YoY) Revenue up 1.8% at ₹172 cr vs ₹169 cr (YoY) EBITDA down 10.3% at ₹49.4 cr vs ₹55 cr (YoY) Margin at 28.7% vs 37.6% (YoY)

30 STOCKS WHICH REPORTED STRONG RESULTS AND STRONG FUTURE GUIDANCE 💪 BOOKMARK THIS POST ✅️ 1. #V2Retail 2. #MCX 3. #SMLMahindra 4. #EicherMotors 5. #MahindraAndMahindra 6. #BSE 7. #OSELDevices 8. #CUPID 9. #KRNHeat 10. #MuthootFinance 11. #YatharthHospital 12. #PNGadgil 13. #InterarchBuilding 14. #JeenaSikho 15. #BlackBuck 16. #DataPatterns 17. #YatraOnline 18. #FrontierSprings 19. #ThomasScott 20. #InfibeamAvenues 21. #AetherIndustries 22. #RenaissanceGlobal 23. #AdvancedEnzyme 24. #Cupid 25. #QualityPower 26. #NisusFinance 27. #TransrailLighting 28. #VishalMegamart 29. #TemboGlobal 30. #ZagglePrepaid No buy/sell reco. I am not an advisor! #StockMarketIndia #stockmarketsindia #Nifty #niftycrash #NiftyBank #NIFTYIT #NIFTYMETAL

#AdvancedEnzyme Q2 Results: Shares surge 8% after strong operating performance #2QWithCNBCTV18 @hormaz_fatakia cnbctv18.com/market/advanced…

Advanced Enzyme Technologies Ltd Q2 FY26 Results:- Revenue 184.53 Cr vs 146.10 Cr ( 26.31% YoY & -0.75% QoQ) PAT 43.33 Cr vs 32.83 Cr ( 31.96% YoY & 8.50% QoQ) #Q2Results #Q2FY26 #stockmarket #nifty #advancedenzyme

Top gainers today #OMInfra 10% #GarudaConstruction 9% #AdvancedEnzyme 9% #ApolloMicroSystem 8% #Everest Industries 8% #Ideaforge 7% #relaxo 7% #Sammaan Capital 6% #HBLENGINEERING 5% #rblbank 5% #NAVA 5% #StockMarket #nifty50 #OptionsTrading #optionbuying #Optionselling

#ADVENZYMES 🧪 Advanced Enzyme Technologies Q1 FY26 Solid comeback with growth in topline and bottom-line! 📊 YoY Highlights: 🔹 Sales: ₹186 Cr ⬆️ 20% 🔹 EBIDT: ₹56.4 Cr ⬆️ 10% 🔹 Net Profit: ₹40.4 Cr ⬆️ 17% 🔹 EPS: ₹3.57 ⬆️ 17% 🔄 QoQ Jump: ➡️ PAT up 51% ➡️ EBIDT up 23% ➡️ Margin expansion led by operating leverage 💡 Focused on enzymes for healthcare, animal nutrition & industrial biotech, ADVENZYMES continues to deliver despite past volatility. 📌 CMP ₹332 | Market Cap ₹3,713 Cr | PE 27.1 🔬 Smallcap compounders with niche tech & global relevance deserve attention when fundamentals align with momentum. #Q1Results #AdvancedEnzyme #Advenzyme #EarningsSeason #BiotechStocks #SmallcapIndia #PrimePaisaResearch

ADVANCED ENZYME #ADVANCEDENZYME DAILY #BREAKOUTSTOCKS CMP: 360 BREAKING OUT to demand zone on DAILIES 🥳 Telegram: t.me/TradeCymatics #StocksInFocus #StockMarket #stocks #Nifty #GIFTNIFTY #stockmarkets

Advanced Enzyme Technologies Ltd Q1 FY26 Results:- Revenue 185.91 cr vs 154.52 cr up by 20.31% YoY & up by 11.21% QoQ PAT After NCI 39.93 cr vs 34.15 cr up by 16.92% YoY & up by 50.78% QoQ #Q1Results #Q1FY26 #stockmarket #nifty #advancedenzyme

Good day🔥 #vprpl 8% 🚀 #exicom 9%🚀 #advancedenzyme 6%🚀 #tanla 4 %🚀 #hutamaki 4%🚀 Which of your stocks moved 5% today?

#JustIn | #AdvancedEnzyme reports its Q4 earnings 👉Net Profit Down 6.71% At ₹26.40 Cr Vs ₹28.30 Cr (YoY) 👉Revenue Up 5.80% At ₹167 Cr Vs ₹158 Cr (YoY) 👉EBITDA Down 18% At ₹45.50 Cr Vs ₹55.50 Cr (YoY) 👉Margin At 27.23% Vs 35.13% (YoY)

List of stocks charts which looks strong For very short term #advancedenzyme #lincoln #esab #nfl Plz share your opinion .✍️ Share which stocks list ✍️

#advancedenzyme No buy / sell reco.